Fortitude Family Office’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.49K Buy
60
+24
+67% +$1.9K ﹤0.01% 1624
2026
Q2
$2.84K Sell
36
-44
-55% -$3.74K ﹤0.01% 1331
2026
Q1
$6.89K Buy
80
+32
+67% +$2.87K ﹤0.01% 800
2025
Q4
$4.19K Buy
48
+35
+269% +$2.66K ﹤0.01% 883
2025
Q3
$745 Sell
13
-43
-77% -$2.48K ﹤0.01% 1644
2025
Q2
$3.31K Buy
+56
New +$3.62K ﹤0.01% 962
2025
Q1
– Sell
-15
Closed -$1.24K – 1209
2024
Q4
$1.24K Sell
15
-8
-35% -$631 ﹤0.01% 1104
2024
Q3
$1.65K Buy
+23
New +$1.62K ﹤0.01% 1037

Other funds holding GMED

Fortitude Family Office's GMED Position: Q3 2026 in Review

Fortitude Family Office increased its Globus Medical (GMED) stake by 67% in Q3 2026, buying an estimated $1.9K and bringing the position to 60 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Fortitude Family Office first reported a position in GMED in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.89K in Q1 2026. 58 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Fortitude Family Office held 60 shares of Globus Medical worth $4.49K as of Q3 2026.
  • Fortitude Family Office bought 24 Globus Medical shares in Q3 2026, an estimated $1.9K.
  • Globus Medical made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1624 holding.
  • Fortitude Family Office first reported a position in Globus Medical in Q3 2024 and has held it in 8 quarters since.
  • Fortitude Family Office's Globus Medical position peaked at $6.89K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.